Recent Blog Posts
View Post: Boehringer Ingelheim And GlaxoSmithKline Back EFA`s Call For ...
12 hours ago by john
Filed in asthma on Nov.29, 2009. Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have announced their support of The European ...
View Blog: Asthma News - http://asthma.jbnewsblog.com/
View Post: Management of chronic obstructive pulmonary disease: moving beyond ...
17 Nov 2009 by copdsurvivor
For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma ...
View Blog: COPD Survivors - http://copdsurvivor.wordpress.com/
View Post: MedWire News - Respiratory - Exhaled breath profiling can ...
19 Nov 2009
MedWire News: Molecular profiling of exhaled breath using an “electronic nose” can accurately distinguish patients with asthma from those with chronic obstructive pulmonary disease (COPD), say Dutch researchers. ...
View Blog: MedWire News - Respiratory - http://www.medwire-news.md/48/Respiratory.html
View Post: Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest ...
17 Nov 2009 by Education For Health
AM211 is an oral, selective antagonist of the receptor DP2, which recent studies have shown to be a potential target for the treatment of asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. Related News ...
View Blog: PR Hub - http://blog.taragana.com/pr/
View Post: HEALTH: Chronic Obstructive Pulmonary Disease
15 Nov 2009 by admin
Chronic Obstructive Pulmonary Disease (COPD) is crippling because it is a progressive disease. We have been endowed with such reserves that we do not reali... ... Use a pocket spirometer that will measure the pulmonary function and a oxygen pulse meter, which measures one's oxygen saturation. If you notice a difference in the values visit the doctor. Although COPD is different from asthma don't be alarmed. The patient's quality of life will be good if he follows his ...
View Blog: Intro2u Blog - http://www.intro2u.net/new/
View Post: UAE Doctors to Investigate Rate of Chronic Respiratory Disease
19 Nov 2009
The first-comprehensive study looking at the rate of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) across the UAE, will be launched next week by doctors at the medical faculty at the ...
View Blog: Eyeofdubai.com : Health & Beauty News - http://www.eyeofdubai.com/
View Post: New discovery may lead to improved asthma drugs
18 Nov 2009 by Ani
September 16th, 2009 WASHINGTON - Researchers at The University of Texas Health Science Centre at Houston have discovered a protein that appears to play a crucial role in development of chronic obstructive pulmonary disease (COPD). ...
View Blog: Health News - http://blog.taragana.com/health/
View Post: New analysis shows SYMBICORT® improved airflow obstruction in ...
9 Nov 2009
SYMBICORT 160/4.5 mcg is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. For patients with COPD, the approved ... SYMBICORT does not replace fast-acting inhalers and should not be used to treat acute symptoms of COPD or asthma. SYMBICORT should not be initiated in patients during rapidly deteriorating or potentially life-threatening episodes of COPD. ...
View Blog: AZ US news feed - http://www.astrazeneca-us.com/

Not Signed In -

